HTS043M Sigma-AldrichChemiScreen™ VPAC1 Membrane Preparation
Human VPAC1 / VIP1 GPCR membrane preparation for Radioligand binding Assays & GTPgammaS binding.
More>> Human VPAC1 / VIP1 GPCR membrane preparation for Radioligand binding Assays & GTPgammaS binding. Less<<Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
Species | Host Cells | Protein Target |
---|---|---|
Human | Chem-1 | VPAC1 / VIP1 |
References |
---|
Product Information | |
---|---|
Format | Membranes |
Presentation | Liquid in packaging buffer: 50 mM Tris pH 7.4, 10% glycerol and 1% BSA no preservatives. Packaging method: Membranes protein were adjusted to the indicated concentration in packaging buffer, rapidly frozen, and stored at -80°C. |
Quality Level | MQ100 |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Storage and Shipping Information | |
---|---|
Storage Conditions | Maintain frozen at -70°C for up to 2 years. Do not freeze and thaw. |
Packaging Information | |
---|---|
Material Size | 200 units |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
HTS043M | 04053252326523 |
Documentation
ChemiScreen™ VPAC1 Membrane Preparation MSDS
Title |
---|
References
Reference overview | Pub Med ID |
---|---|
The significance of vasoactive intestinal peptide in immunomodulation Delgado, Mario, et al Pharmacol Rev, 56:249-90 (2004) 2004 | 15169929 |
International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide Harmar, A J, et al Pharmacol Rev, 50:265-70 (1998) 1998 | 9647867 |